COMMUNIQUÉS West-GlobeNewswire

ProQR Announces Upcoming Presentation at RNA Editing Summit
28/07/2025
LEIDEN, Netherlands & CAMBRIDGE, Mass., July 28, 2025 (GLOBE NEWSWIRE) -- ProQR Therapeutics NV (Nasdaq: PRQR) (ProQR), a company dedicated to changing lives through transformative RNA therapies based on its [...]
Alzamend Neuro to Present at the 2025 Military Health System Research Symposium
28/07/2025
Session Topic is the I nnovation and Current Directions in Military Suicide Prevention, Research, and Programs Presentation Title is Quantitate Differences in Lithium Brain-to-Plasma Exposure in PTSD Subjects Between [...]
IMUNON Announces Stock Dividend Boosting Shareholder Value
28/07/2025
Stock Dividend Reflects Company’s Confidence in its Phase 3 Study, Long-term Growth Potential, and Dedication to Shareholders LAWRENCEVILLE, N.J., July 28, 2025 (GLOBE NEWSWIRE) -- IMUNON , Inc. (Nasdaq: IMNN) , a [...]
NKGen Biotech Presents Troculeucel Mechanism of Action with Corresponding Phase 1 Biomarker Data at the Alzheimer’s Association International Conference 2025
28/07/2025
Troculeucel, a cryopreserved autologous, non-genetically modified NK cell product, appears to cross the blood brain barrier (BBB) via CXCR3, to reduce neuroinflammation via a simple IV administration. Troculeucel was [...]
Supernus Pharmaceuticals Announces Expiration of Hart-Scott-Rodino Waiting Period for Sage Therapeutics, Inc. Tender Offer
28/07/2025
ROCKVILLE, Md., July 28, 2025 (GLOBE NEWSWIRE) -- Supernus Pharmaceuticals, Inc., a Delaware corporation (NASDAQ: SUPN) (" Supernus ", and the "Company"), today announced that the required waiting period under the Hart- [...]
Fifty 1 Labs, Inc. to Host Virtual Shareholder Teleconference Featuring World-Class Leadership Team, including Dr. James Orbinski, who received the Nobel Peace Prize on Behalf of Médecins Sans Frontières
28/07/2025
SEATTLE, July 28, 2025 (GLOBE NEWSWIRE) -- Fifty 1 Labs, Inc. ( OTC: FITY ), a leader in AI-powered health and wellness solutions, today announced it will host a virtual shareholder teleconference on Monday, July 28, [...]
FibroBiologics Files Patent for Methods of Generating Multipotent Cells from Donor Tissue for Clinical Applications
28/07/2025
HOUSTON, July 28, 2025 (GLOBE NEWSWIRE) -- FibroBiologics, Inc. (Nasdaq: FBLG) (“FibroBiologics”), a clinical-stage biotechnology company with 275+ patents issued and pending with a focus on the development of [...]
Enlivex Reaffirms August 18, 2025 As Target Date For Announcement of Phase II Topline Data
28/07/2025
Nes-Ziona, Israel, July 28, 2025 (GLOBE NEWSWIRE) -- Enlivex Therapeutics Ltd. (Nasdaq: ENLV, the “Company”), a clinical-stage macrophage reprogramming immunotherapy company, today announced that all 134 patients in its [...]
Aclaris Therapeutics Announces Leadership Transition
28/07/2025
- Roland Kolbeck, Ph.D. Appointed as Chief Scientific Officer - - Joe Monahan, Ph.D. will Continue to Support Aclaris as Special Scientific Advisor to the Chief Executive Officer through March 2026 as Part of Planned [...]
Emergent Applauds Availability of Over-the-Counter Naloxone in U.S. House of Representatives
28/07/2025
GAITHERSBURG, Md., July 28, 2025 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) today announces its recognition of the U.S. House of Representatives for adding over-the-counter (OTC) naloxone to every AED [...]
New Publication in Expert Review of Anti-infective Therapy Evaluates Brincidofovir as Potential Antiviral Treatment for Mpox
28/07/2025
Ongoing mpox outbreak continues to be a global health threat and is driving need for greater therapeutic research and innovation GAITHERSBURG, Md., July 28, 2025 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS [...]
DLH to Announce Fiscal 2025 Third Quarter Financial Results
28/07/2025
ATLANTA, July 28, 2025 (GLOBE NEWSWIRE) -- DLH Holdings Corp. (NASDAQ: DLHC) (“DLH” or the “Company”), a leading provider of science research and development, systems engineering and integration, and digital [...]
AIM ImmunoTech Reports Positive Mid-year Safety and Efficacy Data from Phase 2 Study Evaluating Ampligen® (rintatolimod) in Combination with AstraZeneca’s Imfinzi® (durvalumab) for the Treatment of Pancreatic Cancer
28/07/2025
Mid-year report of combination therapy demonstrates promising signs of both no significant toxicity and superior PFS and OS OCALA, Fla., July 28, 2025 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE American: AIM) (“AIM” [...]
Capricor Therapeutics and Parent Project Muscular Dystrophy to Host Webinar to Review Latest Developments in the Deramiocel Program for the Treatment of Duchenne Muscular Dystrophy
28/07/2025
– Webinar to be held on Tuesday, July 29, 2025, at 1:00 p.m. ET – SAN DIEGO, July 28, 2025 (GLOBE NEWSWIRE) -- Capricor Therapeutics (NASDAQ: CAPR), a biotechnology company developing transformative cell and exosome- [...]
Eleos Deepens Post-Acute Care Mission with Home Health, Palliative, and Hospice Care Expansion
28/07/2025
The National Alliance for Care at Home Financial Summit showcases the Eleos expansion for the industry CHICAGO and BOSTON, July 28, 2025 (GLOBE NEWSWIRE) -- Eleos Health, the market leader in AI for behavioral health, [...]
Carlsmed’s aprevo® Powers First Personalized Cervical Spine Surgery
28/07/2025
CARLSBAD, Calif., July 28, 2025 (GLOBE NEWSWIRE) -- Carlsmed, Inc. (Nasdaq: CARL) (“Carlsmed”), a medical technology company pioneering AI-enabled personalized spine surgery solutions, today announced the successful [...]
Full Alliance Group Reports Second Quarter Preliminary results, Unveils Expansion into High-Growth Men's Wellness Personal Care and Health Virility segment, Association Digital Benefits, and Expands its Contract Manufacturing Markets
28/07/2025
TAMPA, Fla., July 28, 2025 (GLOBE NEWSWIRE) -- Full Alliance Group, Inc. (OTC: FAGI) today announced preliminary unaudited revenue results for the second quarter of 2025 and provided an exciting outlook for the [...]
Unity Consortium Announces Publication of Journal of Adolescent Health Supplement: “Expert Perspectives on Adolescent Immunization Platform Visits”
28/07/2025
Supplement provides a timely and comprehensive review of adolescent immunization platforms, offering practical insights for healthcare providers navigating a shifting public health landscape VENTNOR CITY, N.J., July 28 [...]
Global Alzheimer’s Platform Foundation and Genentech Collaborate to Expand Access to Alzheimer’s Research
28/07/2025
WASHINGTON, July 28, 2025 (GLOBE NEWSWIRE) -- The Global Alzheimer’s Platform Foundation ® (GAP), an international leader in accelerating clinical trials and improving recruitment, announced a collaboration with [...]

Pages